- Original article
- Open Access
Role of iNOS and eNOS expression in a group of Egyptian diabetic and nondiabetic nephropathy patients
The Egyptian Journal of Internal Medicine volume 25, pages 33–36 (2013)
Introduction and aim
Changes in renal nitric oxide (NO) production have been associated with glomerular hyperfiltration, vascular permeability, albuminuria, glomerulosclerosis, and tubulointerstitial fibrosis. This study aimed at detection of the role of both inducible nitric oxide synthases (iNOS) and endothelial nitric oxide synthases (eNOS) expression in diabetic and nondiabetic nephropathy patients.
Renal biopsies and clinical data of 30 diabetic patients, 10 nondiabetic patients with renal impairment, and 10 control individuals were assessed for eNOS and iNOS expression.
Both glomerular eNOS and iNOS expression levels were increased in diabetic nephropathy patients and this was associated with peripheral arterial occlusive disease. In nondiabetic patients, increased serum creatinine was found to be associated with increased iNOS and eNOS expression, and, together with the control group, they showed increased iNOS expression in tubular and interstitial cells. An association between cigarette smoking and increased expression of both iNOS and eNOS was detected in diabetic patients.
The presence of iNOS is associated with tubular damage resulting in renal failure. The upregulation of NO in diabetes mellitus type 2 may explain the endothelial dysfunction that is associated with almost all diabetic complications.
Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346:1145–1151.
Delles C, Klingbeil AU, Schneider MP. The role of the nitric oxide in the regulation of glomerular hemodynamics in humans. Nephrol Dial Transplant 2004; 19:1392–1397.
Komer R, Andreson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 2003; 284:F1121–F1137.
Heeringa P, Van Goor H, Itoh-Lindstrom Y. Lack of endothelial nitric oxide synthase aggrevates murine accelerated anti-glomerular basement membrane glomerulonephritis. Am J Pathol 2000; 156:879–888.
Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999; 56:393–405.
Goligorsky MS. Endothelial cell dysfunction and nitric oxide synthase. Kidney Int 2000; 58:1360–1376.
Schwartz D, Schwartz IF, Blantz RC. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats. J Lab Clin Med 2001; 137:107–114.
Prabhakar SS. Role of nitric oxide in diabetic nephropathy. Semin Nephrol 2004; 24:333–344.
Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004; 114:5–14.
Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, Hugo CP. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 2006; 69:1654–1661.
Nakayama T, Sato W, Kosugi T, Zhang L, Campbell-Thompson M Yoshimura A, et al. Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse. Am J physiol Renal Physiol 2008; 52:154–178.
Biesenbach G, Grafinger P, Janko O. Influence of cigarette smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients. Clin Nephrol 1997; 48:146–150.
About this article
Cite this article
Aly, M.I., Abdalla, M.N., El Akad, M.H. et al. Role of iNOS and eNOS expression in a group of Egyptian diabetic and nondiabetic nephropathy patients. Egypt J Intern Med 25, 33–36 (2013). https://doi.org/10.7123/01.EJIM.0000425956.33513.05
- diabetic nephropathy
- type 2 diabetes mellitus